• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

Zogenix

Anonymous board for Zogenix
Replies
4
Views
2K
Anonymous
Replies
1
Views
1K
Anonymous
Replies
5
Views
2K
Anonymous
Replies
13
Views
3K
Anonymous
Replies
5
Views
2K
Anonymous
Replies
52
Views
6K
Anonymous
Replies
6
Views
1K
Anonymous